Scrip AMR Round Table Part 5: Fire, Fire!
In a round table discussion held on the sidelines of the ECCMID conference in Amsterdam in April 2016, a panel of experts offered their perspectives on the problem of antimicrobial resistance, and what it will take to protect the world's population from this threat.
In Part 5, panelists John Rex, Matteo Bassetti and Mike Sharland describe how we need to redesign the economic model for antibiotic development and commercialization and how companies are already displaying fresh commitment to the area. They also consider what approaches work to change physicians' behavior.
The round table was chaired by Scrip Editor Eleanor Malone, and the panelists were:
- John Rex, Senior Vice-President and Chief Strategy Officer for AstraZeneca's antibiotics business unit.
- Professor Mike Sharland, Professor of Paediatric Infectious Disease at St George's University Hospital and Chair of a government Expert Advisory Committee on AMR for England.
- Roman Kozlov, Chief Specialist at the Ministry of Health of the Russian Federation in Clinical Microbiology and Antimicrobial Resistance, and a Director at the Institute of Antimicrobial Chemotherapy at the Smolensk State Medical University.
- Matteo Bassetti, head of Infectious Diseases Division of the Santa Maria Misericordia University Hospital in Udine, Italy, and Professor of Infectious Diseases at the School of Medicine and Postgraduate School of Infectious Diseases at the University of Udine.
This Round Table was hosted by Scrip with sponsorship from AstraZeneca.